|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Acute Leukemia | |||||
| Chronic Leukemia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Leukemia | |||||
| Myeloproliferative Disorders | |||||
| 3 | More general conditions related to this trial | ||||
| Bone Marrow Diseases | |||||
| Hematologic Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| 4 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||
| Blood and Marrow Transplant Clinical Trials Network | |||||
| National Cancer Institute (NCI) | |||||